3197 results for «326»
3197 results
Navigating the challenges of calcified lesions
05 Oct 2024 – From AICT-AsiaPCR 2024
Delve into a collection of challenging cases focused on the management of calcified coronary lesions, submitted to the AICT-AsiaPCR 2024 conference. Discover innovative techniques and strategies for tackling heavily calcified vessels, including the use of specialized tools like intravascular lithotripsy and rotational atherectomy. Gain valuable insights...
Image-guided PCI of distal left main disease
05 Oct 2024 – From AICT-AsiaPCR 2024
Exploring a recorded case of image-guided PCI of distal left main disease, as well as a new paradigm in AI-driven imaging, and learn how coronary imaging aids in decision-making, optimises final outcomes, and enhances stent clarity to guide results in complex PCI procedures. Watch now to deepen...
Think SMART! Valve precision and performance matters
05 Oct 2024 – From AICT-AsiaPCR 2024
Explore the impact of the SMART trial results on your practice and decision-making in TAVI. Learn how to achieve precision and control in challenging anatomy with the Evolut FX Platform. Discover the new Evolut FX System and how it can deliver optimal procedural outcomes for all...
Complex calcified left main bifurcation - LIVE case
05 Oct 2024 – From AICT-AsiaPCR 2024
An 82-year-old woman with diabetes, hypertension, a history of Micra and RCA PCI 2 years later, was admitted for NSTEMI. The coronary angiography showed a very calcified distal left main stenosis, a significant and calcified ostial LAD stenosis (medina: 1 1 0), confirmed by IVUS. She...
Tips and tricks for left main PCI
05 Oct 2024 – From AICT-AsiaPCR 2024
Dive into this comprehensive session to learn essential tips and tricks for tackling left main PCI. Gain insights on managing thrombus at the left main and providing hemodynamic support in low-resource settings. Discover techniques to handle complex lesions at the left main, and learn how to...
Complex NSTEMI interventions: Bifurcation and calcification management strategies
05 Oct 2024 – From AICT-AsiaPCR 2024
Explore a diverse array of challenging NSTEMI cases in this session, curated from the AICT-AsiaPCR 2024 conference. Witness innovative approaches to managing bifurcation lesions, tackling calcified and complex coronary anatomy, and navigating double complications. Gain valuable insights from experienced interventionalists as they share their strategies for...
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE Aapproval , its Fourth FDA IDE DEB approval
10 Jan 2023
Over 1,000 patients enrolled in landmark SELUTION DeNovo study
14 Mar 2023
MedAlliance announces enrollment of over 1,660 patients in landmark SELUTION DeNovo study
14 Sep 2023
MedAlliance acquired by Cordis for up to USD 1.135 billion
02 Oct 2023
MedAlliance to be acquired by Cordis
18 Oct 2022
MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval
24 Oct 2022
MedAlliance leads US Sirolimus DEB race: first US patient enrolled into SELUTION SLR coronary sirolimus DEB study
25 Jan 2023
Why hypertension is a major unresolved problem
02 Oct 2024
Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.
Author
Surgical left atrial appendage occlusion in VHD without AF: OPINION Trial
03 Sep 2025
Alex Sticchi provides his take on the results of the OPINION trial presented by Yang Wang at the ESC Congress 2025 in Madrid.
Author
RENOVATE-COMPLEX-PCI: Intravascular imaging-guided versus angiography-guided procedural optimization in complex percutaneous coronary intervention
06 Mar 2023
Daniele Giacoppo reports the main results of the RENOVATE-COMPLEX-PCI trial presented by Joo-Yong Hahn, from the Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, in a Late-Breaking Trial session at the American College of Cardiology (ACC) 2023 / World...
Author
Biocardia receives FDA breakthrough device designation for CardiAMP Cell Therapy System for heart failure
03 Feb 2022